Overview:
The FDA's Quality System Regulation (QSR) requires device manufacturers to identify valid statistical techniques to "establish, control, and verify the acceptability of process capability and product characteristics." When device manufacturers analyze CA&PA; information, they must also use "appropriate statistical methodology". Some manufacturers are not clear about all of this. Others are nervous that their approach is sufficient.
In addition, sampling plans must be valid, documented, adequate, and reviewed based on changes.
These issues can create a patchwork of techniques without a coherent methodology. This seminar helps resolve the problem.
Why you should attend:
The seminar starts with an understanding of the regulations through a variety of sources. This includes the Quality System Inspection Technique (QSIT) as well as Warning Letters.
The FDA regulations don't provide the available techniques or their application. This is the role of ISO/TR 10017:2003 Guidance on statistical techniques for ISO 9001:2000. While this guidance applies to an earlier version of ISO 9001, both FDA QSR and ISO 13485 are ISO 9001 successors.
The guidance document provides a list of statistical techniques and explains how each applies to the particular ISO 9001 clauses. Mapping these applications to FDA QSR is straightforward and provides a robust approach to help a manufacturer identify and implement the appropriate methods. The seminar provides the cross reference to help you decide on which techniques to apply.
The seminar explains the methods, shows how they apply using medical device examples, and includes exercises for participants to solidify understanding.
Who will benefit:
All medical device manufacturers that apply FDA QSR or ISO 13485:2003
· Quality Managers
· Quality Engineers
· Quality Assurance and Quality Control
· Regulatory Affairs Managers
· Regulatory Affairs Professionals
· R&D; Managers
· R&D; Engineers
· Product Design and Development
· Operations Managers
· Production Managers and Supervisors
· Manufacturing Engineers
· Risk Managers
· Complaint system team members
· CA&PA; team members
Day One
Lecture 1: Statistical Techniques in FDA QSR
· QSIT
· Warning Letters
Lecture 2: Applications of ISO/TR 10017:2003
Lecture 3: Descriptive Statistics
Lecture 4: Hypothesis Testing
Lecture 5: Regression Analysis
Day Two:
Lecture 6: Acceptance Sampling Plans (Attributes and Variables)
Lecture 7: Statistical Process Control (Attributes and Variables)
Lecture 8: Process Capability Analysis
Lecture 9: Measurement Analysis
Dan O'Leary is the President of Ombu Enterprises, LLC, a company offering training and execution in Operational Excellence, focused on analytic skills and a systems approach to operations management. Dan has more than 30 years experience in quality, operations, and program management in regulated industries including aviation, defense, medical devices, and clinical labs. He has a Masters Degree in Mathematics; is an ASQ certified Biomedical Auditor, Quality Auditor, Quality Engineer, Reliability Engineer, and Six Sigma Black Belt; and is certified by APICS in Resource Management.
Location: Philadelphia, PA Date: July 30 & 31, 2015 Time: 9:00 AM to 6:00 PM EDT
Venue: DoubleTree by Hilton Hotel Philadelphia Center City
Venue Address: 237 South Broad Street, Philadelphia, Pennsylvania, 19107-5686, USA
Price: $1,295.00 (Seminar for One Delegate)
Register now and save $200. (Early Bird)
Until April 30, Early Bird Price: $1,295.00
From May 01 to July 28, Regular Price: $1,495.00
Contact Information:
NetZealous LLC,
DBA GlobalCompliancePanel
161 Mission Falls Lane,
Suite 216, Fremont, CA 94539, USA
USA Phone: 800-447-9407
Fax: 302-288-6884
support@globalcompliancepanel.com
http://www.globalcompliancepanel.com
Event Registration Link - http://bit.ly/1zzZDvv
Overview: The main document from a regulatory perspective in the development...
Q
Overview: This seminar is mainly based on the IEC62304:2006 standard and will...
Q
Overview: This course will present, in one place, the regulations and...
Q
Overview: We will be discussing the history and evolution of HIPAA...
Q
Overview: This two day seminar will provide the foundation for the...
Q
Overview: Most specialists strongly recommend to sample every meter of the...
Q
Overview: QMS is the catch phrase for accreditation and is the backbone of...
Q
Overview: This hands-on course will provide attendees with an understanding of...
Q
Overview: Upon completing this course participants should: · ...
Q
Overview: Prior to developing a process control plan as part of an overall...
Q
Overview: Topics included will include the filing of New Drug Submissions for...
Q
Overview: This course provides a basic overview of the laws and regulations...
Q
Overview: Why companies are prone to having past problems in new devices? One...
Q
Overview: The 2-day seminar begins with an examination of ISO and FDA...
Q
Overview: Prior to developing a process control plan as part of an overall...
Q
Overview: This program is designed to provide participants...
Q
Overview: FDA's and the Customs and Border Patrol Service (CBP) have become...
Q
Overview Throughout 21 CFR and guidance documents for the pharmaceutical,...
Q
Overview: We will be discussing the history and evolution of HIPAA...
Q
Overview: This 2-day seminar provides a 1-day introduction to the statistical...
Q
Overview: With all of the deadlines, projects, and tasks that you have to do...
Q
Overview: Real world examples of what to expect, and what to prepare for...
Q
Overview: This course provides a basic overview of the laws and regulations...
Q
Overview: Upon completing this course participants should: · ...
Q
Overview: The FDA recalls related to software performance are on the increase...
Q
Overview: QMS is the catch phrase for accreditation and is the backbone of...
Q
Overview: Prepare yourself to take on the role of the Corporate Controller....
Q
Login to comment